MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
TVRD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Tvardi Therapeutics (TVRD) Ownership - Who owns Tvardi Therapeutics?

Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
3 Sugar Creek Center boulevard
Phone
+1 713 489-8654
Employees
12
Web
https://www.tvarditherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
17.74M
P/E Ratio
N/A
Total Cash
15.77M
Projected Growth
N/A
Total Debt
145K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.18
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
TVRD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for TVRD
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
3 Sugar Creek Center boulevard
Phone
+1 713 489-8654
Employees
12
Web
https://www.tvarditherapeutics.com
Who owns Tvardi Therapeutics? TVRD symbol Ownership - Tickeron.com